171 related articles for article (PubMed ID: 35167731)
1. Evaluation of the treatment of equine glandular gastric disease with either long-acting-injectable or oral omeprazole.
Gough S; Hallowell G; Rendle D
Vet Med Sci; 2022 Mar; 8(2):561-567. PubMed ID: 35167731
[TBL] [Abstract][Full Text] [Related]
2. A study investigating the treatment of equine squamous gastric disease with long-acting injectable or oral omeprazole.
Gough S; Hallowell G; Rendle D
Vet Med Sci; 2020 May; 6(2):235-241. PubMed ID: 31945806
[TBL] [Abstract][Full Text] [Related]
3. Five- versus seven-day dosing intervals of extended-release injectable omeprazole in the treatment of equine squamous and glandular gastric disease.
Sundra T; Kelty E; Rendle D
Equine Vet J; 2024 Jan; 56(1):51-58. PubMed ID: 36977610
[TBL] [Abstract][Full Text] [Related]
4. Misoprostol is superior to combined omeprazole-sucralfate for the treatment of equine gastric glandular disease.
Varley G; Bowen IM; Habershon-Butcher JL; Nicholls V; Hallowell GD
Equine Vet J; 2019 Sep; 51(5):575-580. PubMed ID: 30809869
[TBL] [Abstract][Full Text] [Related]
5. Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Pratt SL; Bowen M; Hallowell GH; Shipman E; Bailey J; Redpath A
Vet Med Sci; 2023 Jan; 9(1):150-157. PubMed ID: 36495212
[TBL] [Abstract][Full Text] [Related]
6. Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
Ricord M; Andrews FM; Yñiguez FJM; Keowen M; Garza F; Paul L; Chapman A; Banse HE
Equine Vet J; 2021 Mar; 53(2):356-363. PubMed ID: 32697849
[TBL] [Abstract][Full Text] [Related]
7. Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome.
Bush J; van den Boom R; Franklin S
Equine Vet J; 2018 Jan; 50(1):34-40. PubMed ID: 28555939
[TBL] [Abstract][Full Text] [Related]
8. Comparison of oral esomeprazole and oral omeprazole in the treatment of equine squamous gastric disease.
Sundra T; Gough S; Rossi G; Kelty E; Rendle D
Equine Vet J; 2023 Sep; ():. PubMed ID: 37678812
[TBL] [Abstract][Full Text] [Related]
9. Effect of omeprazole and sucralfate on gastrointestinal injury in a fasting/NSAID model.
Bishop RC; Kemper AM; Wilkins PA; McCoy AM
Equine Vet J; 2021 Oct; ():. PubMed ID: 34719063
[TBL] [Abstract][Full Text] [Related]
10. Preliminary investigations into a novel, long-acting, injectable, intramuscular formulation of omeprazole in the horse.
Sykes BW; Kathawala K; Song Y; Garg S; Page SW; Underwood C; Mills PC
Equine Vet J; 2017 Nov; 49(6):795-801. PubMed ID: 28397996
[TBL] [Abstract][Full Text] [Related]
11. A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial.
Sykes BW; Sykes KM; Hallowell GD
Equine Vet J; 2014 Jul; 46(4):416-21. PubMed ID: 24102898
[TBL] [Abstract][Full Text] [Related]
12. Equine gastric ulcer syndrome in adult horses.
van den Boom R
Vet J; 2022; 283-284():105830. PubMed ID: 35472513
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial.
Busechian S; Conti MB; Sgorbini M; Conte G; Marchesi MC; Pieramati C; Zappulla F; Vitale V; Rueca F
J Equine Vet Sci; 2023 Jul; 126():104296. PubMed ID: 37003396
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of a combination of phenylbutazone and omeprazole on chronic lameness in Mongolian horses.
Li Z; Du S; Wang X; Zhang L; Liu X; Fan Q; Yang H; Gao R
Equine Vet J; 2024 May; 56(3):562-572. PubMed ID: 37337455
[TBL] [Abstract][Full Text] [Related]
15. A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial.
Sykes BW; Sykes KM; Hallowell GD
Equine Vet J; 2015 May; 47(3):285-90. PubMed ID: 24761780
[TBL] [Abstract][Full Text] [Related]
16. Equine gamma herpesvirus presence and viral load are not associated with equine glandular gastric disease.
Thompson RN; Pearson E; McDonough SP; Iannitti H; Van de Walle GR; Banse H; Perkins GA; Tomlinson JE
Am J Vet Res; 2024 Jun; 85(6):. PubMed ID: 38484465
[TBL] [Abstract][Full Text] [Related]
17. Management factors and clinical implications of glandular and squamous gastric disease in horses.
Sykes BW; Bowen M; Habershon-Butcher JL; Green M; Hallowell GD
J Vet Intern Med; 2019 Jan; 33(1):233-240. PubMed ID: 30499188
[TBL] [Abstract][Full Text] [Related]
18. Characterization of gastrointestinal inflammatory cell type in equine glandular gastric disease.
Banse HE; Piero FD; Andrews FM; Garcia-Abarca N; Watanabe TTN
Am J Vet Res; 2023 Dec; 84(12):. PubMed ID: 38041943
[TBL] [Abstract][Full Text] [Related]
19. Increased adrenocortical response to adrenocorticotropic hormone (ACTH) in sport horses with equine glandular gastric disease (EGGD).
Scheidegger MD; Gerber V; Bruckmaier RM; van der Kolk JH; Burger D; Ramseyer A
Vet J; 2017 Oct; 228():7-12. PubMed ID: 29153110
[TBL] [Abstract][Full Text] [Related]
20. Gastric microbiome in horses with and without equine glandular gastric disease.
Paul LJ; Ericsson AC; Andrews FM; Keowen ML; Morales Yniguez F; Garza F; Banse HE
J Vet Intern Med; 2021 Sep; 35(5):2458-2464. PubMed ID: 34351018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
